More than 3 million people worldwide suffer from end-stage renal disease (ESRD). A small percentage of them receive kidney transplants, but there are not nearly enough organ donors to meet demand and the procedure is rife with complications. The vast majority of patients suffering from ESRD rely on hemodialysis, an invasive treatment that requires going to a dialysis center three to four times a week for sessions that can last up to four hours at a time. Tagging Options Domain:  All Sites Keywords:  Medical Polymers read more

Read the original:
Portable in-home hemodialysis device may be in clinical trials by 2017